<DOC>
	<DOC>NCT01519934</DOC>
	<brief_summary>Up to 120 subjects within the study site's practice who have already had an Ultherapy™ treatment to the face and neck will be enrolled to monitor treatment effectiveness. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained at each follow-up visit.</brief_summary>
	<brief_title>A Retrospective Study to Evaluate the Effectiveness of the Ulthera System</brief_title>
	<detailed_description>This is a retrospective, single-center clinical trial to evaluate the efficacy of the Ulthera System for non-invasive treatment of skin texture and laxity six months after treatment. Global Aesthetic Improvement Scale scores, patient satisfaction questionnaires, and quality of life questionnaires will be obtained.</detailed_description>
	<mesh_term>Cutis Laxa</mesh_term>
	<criteria>Male or female, age 2585 years. Subject in good health. Received Ultherapy™ treatment prior to or on October 1, 2011, and must have had pretreatment baseline photographs taken. Willingness and ability to comply with protocol requirements, including returning for followup visits. Absence of physical or psychological conditions unacceptable to the investigator. Presence of an active systemic or local skin disease that may affect wound healing. Significant scarring in areas treated. Open wounds or lesions in the areas treated. Severe or cystic acne on the areas treated. Inability to understand the protocol or to give informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Ulthera® System</keyword>
	<keyword>Ultherapy™ Treatment</keyword>
	<keyword>Ulthera, Inc.</keyword>
	<keyword>Ultrasound treatment for skin tightening</keyword>
</DOC>